Activity of AMP against experimental herpes simplex virus type 1 infections in mice.
AUTOR(ES)
Blue, W T
RESUMO
Administration of AMP soon after inoculation of mice with herpes simplex virus type 1 inhibited development of virus-induced lesions and appeared to prevent establishment of virus latency. These effects were dependent on both the AMP dose and the time of AMP administration. Regression of herpes simplex virus type 1-induced lesions was also accelerated significantly by AMP treatment in a time- and dose-dependent manner.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=185946Documentos Relacionados
- Xylotubercidin against herpes simplex virus type 2 in mice.
- Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice.
- Herpes simplex virus type 1-induced hydrocephalus in mice.
- Experimental herpes simplex virus carditis in mice.
- Efficacy of 2'-nor-2'-deoxyguanosine treatment for orofacial herpes simplex virus type 1 skin infections in mice.
